WDB coco CO.,LTD. Logo

WDB coco CO.,LTD.

CRO for pharma & med devices specializing in safety info, PMS & full lifecycle support.

7079 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区晴海一丁目8−11
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

WDB coco CO., LTD. is a Contract Research Organization (CRO) that provides specialized support services for the pharmaceutical and medical device industries. The company's core expertise lies in safety information management (pharmacovigilance) and post-marketing surveillance (PMS). Its comprehensive service portfolio also encompasses support for clinical research, clinical trials, regulatory affairs and quality assurance (RA/QA), and the development of medical devices. WDB coco focuses on delivering operational support throughout the product lifecycle, from development and regulatory submission to post-marketing activities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 02:44
Governance Information
内部統制報告書-第42期(2024/04/01-2025/03/31)
Japanese 23.8 KB
2025-06-30 02:39
Regulatory News Service
確認書
Japanese 8.7 KB
2025-06-30 02:34
Annual Report
有価証券報告書-第42期(2024/04/01-2025/03/31)
Japanese 852.8 KB
2025-06-25 07:27
Post-Annual General Meeting Information
臨時報告書
Japanese 23.7 KB
2024-11-14 02:00
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-11-14 01:54
Interim Report
半期報告書-第42期(2024/04/01-2025/03/31)
Japanese 178.8 KB
2024-06-28 04:07
Regulatory News Service
内部統制報告書-第41期(2023/04/01-2024/03/31)
Japanese 22.8 KB
2024-06-28 03:56
Regulatory News Service
確認書
Japanese 8.7 KB
2024-06-28 03:50
Annual Report
有価証券報告書-第41期(2023/04/01-2024/03/31)
Japanese 846.0 KB
2024-06-24 03:30
Post-Annual General Meeting Information
臨時報告書
Japanese 23.5 KB
2024-02-14 02:03
Regulatory News Service
確認書
Japanese 8.7 KB
2024-02-14 01:50
Quarterly Report
四半期報告書-第41期第3四半期(2023/10/01-2023/12/31)
Japanese 143.4 KB
2023-11-14 01:44
Regulatory News Service
確認書
Japanese 8.7 KB
2023-11-14 01:35
Quarterly Report
四半期報告書-第41期第2四半期(2023/07/01-2023/09/30)
Japanese 178.7 KB
2023-08-10 03:59
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all WDB coco CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for WDB coco CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan 3970
INTAGE HOLDINGS Inc. Logo
Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.
Japan 4326
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France ALINT
Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan 7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan 9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea 287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea 216400

Talk to a Data Expert

Have a question? We'll get back to you promptly.